metyrapone has been researched along with Demyelinating Diseases in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KEPES, JJ | 1 |
| REECE, CA | 1 |
| OXLEY, DK | 1 |
| Simopoulos, AP | 1 |
| Roth, JA | 1 |
| Golde, DW | 1 |
| Bartter, FC | 1 |
2 other studies available for metyrapone and Demyelinating Diseases
| Article | Year |
|---|---|
CENTRAL PONTINE MYELINOLYSIS IN A 7-YEAR-OLD BOY.
Topics: Child; Craniopharyngioma; Dehydration; Demyelinating Diseases; Humans; Ketones; Male; Metyrapone; Mi | 1965 |
Subacute necrotizing encephalomyelopathy with vacuolated cells in the bone marrow.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Amino Acids; A | 1972 |